These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11708494)

  • 1. DNA-based detection of prostate cancer in blood, urine, and ejaculates.
    Goessl C; Müller M; Heicappell R; Krause H; Miller K
    Ann N Y Acad Sci; 2001 Sep; 945():51-8. PubMed ID: 11708494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
    Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
    Jerónimo C; Usadel H; Henrique R; Silva C; Oliveira J; Lopes C; Sidransky D
    Urology; 2002 Dec; 60(6):1131-5. PubMed ID: 12475696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-based detection of prostate cancer in urine after prostatic massage.
    Goessl C; Müller M; Heicappell R; Krause H; Straub B; Schrader M; Miller K
    Urology; 2001 Sep; 58(3):335-8. PubMed ID: 11549474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
    Henrique R; Jerónimo C
    Eur Urol; 2004 Nov; 46(5):660-9; discussion 669. PubMed ID: 15474280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P; Esteller M; Herman JG; Schoenberg M; Jeronimo C; Sanchez-Cespedes M; Chow NH; Grasso M; Wu L; Westra WB; Sidransky D
    Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
    Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
    Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients.
    Haluskova J; Lachvac L; Nagy V
    Bratisl Lek Listy; 2015; 116(2):79-82. PubMed ID: 25665470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML; Nakayama M; Lee SM; De Marzo AM; Nelson WG
    Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
    Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis.
    Wu T; Giovannucci E; Welge J; Mallick P; Tang WY; Ho SM
    Br J Cancer; 2011 Jun; 105(1):65-73. PubMed ID: 21654682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG
    J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.
    Jerónimo C; Usadel H; Henrique R; Oliveira J; Lopes C; Nelson WG; Sidransky D
    J Natl Cancer Inst; 2001 Nov; 93(22):1747-52. PubMed ID: 11717336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
    Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
    Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
    Bernardini S; Miano R; Iori R; Finazzi-Agrò E; Palmieri G; Ballerini S; Angeloni C; Orlandi A; Bellincampi L; Cortese C; Federici G
    Clin Chim Acta; 2004 Dec; 350(1-2):181-8. PubMed ID: 15530476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
    Suh CI; Shanafelt T; May DJ; Shroyer KR; Bobak JB; Crawford ED; Miller GJ; Markham N; Glode LM
    Mol Cell Probes; 2000 Aug; 14(4):211-7. PubMed ID: 10970725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.